Research graph
References from Electronic patient-reported outcomes platforms to shift from episodic to continuous oncology in breast cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Breast cancer treatment: a review
10.1001/jama.2018.19323 · 2019 · External reference
Breast cancer
10.1016/s0140-6736(20)32381-3 · 2021 · External reference
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
10.1200/jco.2014.57.9334 · 2015 · External reference
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
10.1016/j.annonc.2020.09.010 · 2020 · External reference
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes
10.1093/jnci/djp386 · 2009 · External reference
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials
10.1016/j.esmoop.2024.102941 · 2024 · External reference
Integrating patient-reported outcomes into the care of people with advanced cancer – a practical guide
10.1200/edbk_438512 · 2024 · External reference
Adherence to adjuvant endocrine therapy in breast cancer patients
10.3390/curroncol30020112 · 2023 · External reference
Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues
10.1111/hex.13254 · 2021 · External reference
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension
10.1001/jama.2013.879 · 2013 · External reference
Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients
10.1016/j.ejca.2021.12.020 · 2022 · External reference
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology
10.1093/jnci/85.5.365 · 1993 · External reference
Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer
10.1016/s0959-8049(01)00448-8 · 2002 · External reference
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure
10.1200/jco.1993.11.3.570 · 1993 · External reference
An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45
10.1016/j.annonc.2019.10.027 · 2020 · External reference
Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument
10.1200/jco.1997.15.3.974 · 1997 · External reference
Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q
10.1097/prs.0b013e3181aee807 · 2009 · External reference
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
10.1093/jnci/dju244 · 2014 · External reference
Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms
10.1158/1078-0432.ccr-15-2035 · 2016 · External reference
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
10.1016/s1470-2045(16)30510-1 · 2016 · External reference
A review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020
10.3389/fmed.2022.968272 · 2022 · External reference
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium
10.1016/s1470-2045(19)30790-9 · 2020 · External reference
Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study
10.1016/j.annonc.2023.04.516 · 2023 · External reference
Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial
10.1200/jco.2015.63.0830 · 2016 · External reference
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial
10.1038/s41591-022-01788-1 · 2022 · External reference
How to design a remote patient monitoring system? a french case study
10.1186/s12913-020-05293-4 · 2020 · External reference
Capturing patient-reported outcome (PRO) data electronically: the past, present, and promise of ePRO measurement in clinical trials
10.1007/s40271-014-0090-z · 2015 · External reference
US FDA patient-reported outcome guidance: great expectations and unintended consequences
10.1586/14737167.2013.814957 · 2013 · External reference
Measuring quality of life in routine oncology practice improves communication and patient well being: a randomized controlled trial
10.1200/jco.2004.06.078 · 2004 · External reference
Chemotherapy-related neuropathic symptom management: a randomized trial of an automated symptom-monitoring system paired with nurse practitioner follow-up
2018 · External reference
Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT
10.1002/cam4.1002 · 2017 · External reference
Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
10.1001/jama.2017.7156 · 2017 · External reference
Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial
10.1001/jama.2022.9265 · 2022 · External reference
Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy
10.1200/jco.20.02015 · 2021 · External reference
Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer
10.1001/jama.2018.18085 · 2019 · External reference
Digital therapeutic (mika) targeting distress in patients with cancer: results from a nationwide waitlist randomized controlled trial
10.2196/51949 · 2024 · External reference
Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review
10.1093/jnci/djr541 · 2012 · External reference
Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer
10.1093/oxfordjournals.jncimonographs.a003451 · 2001 · External reference
Electronic patient-reported outcome measures (ePROs) as tools for assessing health-related quality of life (HRQoL) in women with gynecologic and breast cancers: a systematic review
10.1177/20552076241297041 · 2024 · External reference
Validation of the electronic version of the BREAST-Q in the army of women study
10.1016/j.breast.2017.02.015 · 2017 · External reference
Patient-reported outcome measures for breast implant surgery: a pilot study
10.1093/asj/sjz023 · 2019 · External reference
A web- and mobile-based intervention for women treated for breast cancer to manage chronic pain and symptoms related to lymphedema: results of a randomized clinical trial
10.2196/29485 · 2022 · External reference
Evaluating the feasibility of an electronic patient-reported outcomes platform integrating electronic health records and a mobile messaging app in breast cancer radiotherapy: retrospective cross-sectional study
10.2196/67514 · 2026 · External reference
Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: results from a substudy of the VIRGO observational cohort study
10.1016/j.breast.2014.08.004 · 2014 · External reference
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial
10.1007/s10549-015-3633-7 · 2015 · External reference
The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2-negative metastatic breast cancer: experience from the patient perspective
10.1586/14737167.2014.949243 · 2014 · External reference
10.1093/annonc/mdw139
10.1093/annonc/mdw139 · 2016 · External reference
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial
10.1016/j.annonc.2023.05.003 · 2023 · External reference
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy
10.1007/s12282-023-01537-3 · 2024 · External reference
Effectiveness of a smartphone application as a support tool for patients undergoing breast cancer chemotherapy: a randomized controlled trial
10.1016/j.clbc.2020.01.004 · 2020 · External reference
A mobile app to stabilize daily functional activity of breast cancer patients in collaboration with the physician: a randomized controlled clinical trial
10.2196/jmir.6414 · 2016 · External reference
Satisfaction with care and adherence to treatment when using patient reported outcomes to individualize follow-up care for women with early breast cancer – a pilot randomized controlled trial
10.1080/0284186x.2020.1717604 · 2020 · External reference
Application of personal health record in enhancing the quality of life in patients with breast cancer who received adjuvant hormonal therapy
10.4274/ejbh.galenos.2022.2021-12-2 · 2022 · External reference
An electronic patient-reported outcome tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) questionnaire for measuring the health-related quality of life in patients with breast cancer: reliability study
10.2196/10004 · 2019 · External reference
Comparison of the real-world reporting of symptoms and well being for the HER2-directed trastuzumab biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of electronic patient-reported outcomes
10.2196/54178 · 2024 · External reference
Electronic patient-reported outcomes with vital sign monitoring during trastuzumab deruxtecan therapy: the PRO-DUCE Randomized Clinical Trial
10.1001/jamanetworkopen.2025.27403 · 2025 · External reference
eHealth intervention to manage symptoms for patients with cancer on immunotherapy (SOFIA): a study protocol for a randomised controlled external pilot trial
10.1136/bmjopen-2020-047277 · 2021 · External reference
Efficiency of electronic health record assessment of patient-reported outcomes after cancer immunotherapy: a randomized clinical trial
10.1001/jamanetworkopen.2022.4427 · 2022 · External reference
Determining issues of importance for the evaluation of quality of life and patient-reported outcomes in breast cancer: results of a survey of 1072 patients
10.1007/s10549-015-3420-5 · 2015 · External reference
PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients-study protocol for a randomised controlled trial
10.1186/s13063-021-05642-6 · 2021 · External reference
The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: results of a population-based retrospective matched cohort analysis
10.1002/cam4.3374 · 2020 · External reference
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
10.1016/j.annonc.2022.04.007 · 2022 · External reference
Distress management, version 3.2019, NCCN clinical practice guidelines in oncology
10.6004/jnccn.2019.0048 · 2019 · External reference
Getting ready for real-world use of electronic patient-reported outcomes (ePROs) for patients with cancer: a national comprehensive cancer network ePRO workgroup paper
10.1002/cncr.34844 · 2023 · External reference
Tenets for implementing electronic patient-reported outcomes for remote symptom monitoring during cancer treatment
10.1200/cci.22.00187 · 2023 · External reference
Real time remote symptom monitoring during chemotherapy for cancer: European Multicentre Randomised Controlled Trial (eSMART)
10.1136/bmj.n1647 · 2021 · External reference
eSyM: an electronic health record-integrated patient-reported outcomes-based cancer symptom management program used by six diverse health systems
10.1200/cci.21.00137 · 2022 · External reference
Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium
10.1016/j.lanepe.2024.101005 · 2024 · External reference
Longitudinal assessment of real-world patient adherence: a 12-month electronic patient-reported outcomes follow-up of women with early breast cancer undergoing treatment
2024 · External reference
Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992)
10.1177/1740774516655101 · 2016 · External reference
Electronic patient-reported outcomes during breast cancer adjuvant radiotherapy
10.1016/j.clbc.2020.10.004 · 2021 · External reference
Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT Trial
10.1200/cci.20.00081 · 2020 · External reference
Implementation of an electronic patient-reported outcome app for health-related quality of life in breast cancer patients: evaluation and acceptability analysis in a two-center prospective trial
10.2196/16128 · 2022 · External reference
Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation
10.1038/s41523-022-00414-0 · 2022 · External reference
Who is more likely to adopt and comply with the electronic patient-reported outcome measure (ePROM) mobile application? A real-world study with cancer patients undergoing active treatment
2022 · External reference
Electronic-based patient-reported outcomes: willingness, needs, and barriers in adjuvant and metastatic breast cancer patients
10.2196/cancer.6996 · 2017 · External reference
Benefits and disadvantages of electronic patient-reported outcome measures: systematic review
10.2196/15588 · 2020 · External reference
The advantages, disadvantages, threats, and opportunities of electronic patient-reported outcome systems in cancer: a systematic review
10.1177/20552076241257146 · 2024 · External reference
The role of patient-reported outcome measures in trials of artificial intelligence health technologies: a systematic evaluation of ClinicalTrials.gov records (1997–2022)
10.1016/s2589-7500(22)00249-7 · 2023 · External reference
Electronic patient-reported outcomes as digital therapeutics for patients with cancer: a narrative review of current practices and future directions
10.1007/s10147-024-02651-8 · 2025 · External reference
